Recent News

• Symposium’23 Program
  “Innovative drugs & health products,
  imaging & theranostics agents –
  cell & gene biotherapies”, March 17, 2023, 13:30

  Program here.

• 3e matinée Carnot Star “9-12 Recherche-Industrie” dédiée à l’Imagerie, 17 Mars 2023, 8h30

  Programme ici, inscriptions ici, .

• FairEmbo en Afrique : “Ce médecin marseillais sauve des femmes avec des bouts de ficelle”

  FairEmbo en Afrique : l’Embolisation-pour-tous franchit une nouvelle étape. Plus d’informations ici.

• Webinar: Discover Radiotheranostics in Nuclear Medicine (15 Sept. 2022)

  Plus d’informations ici.

• Le projet EmboBio, développé au CERIMED, a reçu le prix de l’innovation AP-HM 2022

  Plus d’informations sur le prix AP-HM de l’innovation 2022 ici. Plus d’informations sur le projet Embobio dans cette vidéo.

• CERIMED OBTAINS DUAL ISO 9001:2015 AND NF X50-900:2016 CERTIFICATION FOR ITS PRE-CLINICAL RADIOLOGICAL AND NUCLEAR SERVICE AND INNOVATION ACTIVITIES

  On June 5, 2022, the European Center for Research in Medical Imaging (CERIMED, UMS AMU CNRS 2012) obtained dual ISO 9001:2015 and NF-X50-900 certification for its pre-clinical

• Symposium’21 Program
  “Innovative drugs & health products,
  imaging & theranostics agents –
  cell & gene biotherapies”

  Program here.

• VECT-HORUS and CERIMED Announce Collaboration to Support the Development of VECT-HORUS’ Theragnostic Agents

  VECT-HORUS, a biotechnology company that designs and develops vectors that facilitate the targeted delivery of therapeutic molecules and imaging agents, has announced the signing of a collaboration

• FAIR-Embo hopes to spread safe, cheap embolization around the world

  We are proud to anounce that Pr Vincent Vidal (Marseille, France), Head of the Experimental Interventional Radiology Laboratory hosted at CERIMED, and colleagues have demonstrated the in vivo feasibility